On the last day of August 2026, a Singapore-based research network earned a designation that transforms local expertise into global obligation. ADVANCE-ID, housed at the National University of Singapore and spanning more than 30 hospitals across Asia, was formally recognised as a WHO collaborating centre — the first in the Western Pacific dedicated to clinical trials. In a region that has long borne a disproportionate share of antimicrobial resistance deaths, this appointment is less a celebration than a commission: to build the shared scientific infrastructure that no single nation could cons